Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology

OBJECTIVE: We developed clinical practice guidelines to assess the individual risk–benefit profile of androgen replacement therapy in adult male hypogonadism (HG), defined by the presence of specific signs and symptoms and serum testosterone (T) below 12 nmol/L. PARTICIPANTS: The task force consiste...

Descripción completa

Detalles Bibliográficos
Autores principales: Isidori, A. M., Balercia, G., Calogero, A. E., Corona, G., Ferlin, A., Francavilla, S., Santi, D., Maggi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282686/
https://www.ncbi.nlm.nih.gov/pubmed/25384570
http://dx.doi.org/10.1007/s40618-014-0155-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282686/
https://www.ncbi.nlm.nih.gov/pubmed/25384570
http://dx.doi.org/10.1007/s40618-014-0155-9

Ejemplares similares